Safety and Pharmacokinetics of TT30 in Subjects With Paroxysmal Nocturnal Hemoglobinuria (PNH)

NCT01335165 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

10

Enrollment

INDUSTRY

Sponsor class

Stopped Inability to reach enrollment as planned

Conditions

Paroxysmal Nocturnal Hemoglobinuria (PNH)

Interventions

DRUG: ALXN1102
DRUG: ALXN1103

Sponsor

Alexion Pharmaceuticals, Inc.